Terms: = Lymphoma AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Prognosis
180 results:
1. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell lymphoma.
Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
[TBL] [Abstract] [Full Text] [Related]
2. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations.
Pemmaraju N; Madanat YF; Rizzieri D; Fazal S; Rampal R; Mannis G; Wang ES; Foran J; Lane AA
Leuk Lymphoma; 2024 May; 65(5):548-559. PubMed ID: 38391126
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
4. Leukemia-associated aberrant immunophenotype: A flow cytometry-based experience of 110 cases from a tertiary care center in Northern India.
Venugopalan RK; Singh N; Anthony ML; Kunnumbrath A; Gupta AK; Nath UK; Chowdhury N; Chandra H
J Cancer Res Ther; 2023; 19(5):1335-1339. PubMed ID: 37787304
[TBL] [Abstract] [Full Text] [Related]
5. Assessment of essential and toxic elemental concentrations in tumor and non-tumor tissues with risk of colorectal carcinoma in Pakistan.
Qayyum MA; Farooq T; Baig A; Bokhari TH; Anjum MN; Mahmood MH; Ashraf AR; Muddassir K; Ahmad M
J Trace Elem Med Biol; 2023 Sep; 79():127234. PubMed ID: 37302218
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of characteristics of four patients with adrenal unicentric Castleman disease.
Yu H; Wang Y; Li Y; Du J; Guo Q; Gu W; Lyu Z; Dou J; Mu Y; Zang L
Front Endocrinol (Lausanne); 2023; 14():1181929. PubMed ID: 37265694
[TBL] [Abstract] [Full Text] [Related]
7. Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL.
Aparicio-Pérez C; Carmona M; Benabdellah K; Herrera C
Front Immunol; 2023; 14():1165870. PubMed ID: 37122700
[TBL] [Abstract] [Full Text] [Related]
8. The prognostic and therapeutic potentials of ctla-4 in hematological malignancies.
Sadeghi M; Khodakarami A; Ahmadi A; Fathi M; Gholizadeh Navashenaq J; Mohammadi H; Yousefi M; Hojjat-Farsangi M; Movasaghpour Akbari AA; Jadidi-Niaragh F
Expert Opin Ther Targets; 2022 Dec; 26(12):1057-1071. PubMed ID: 36683579
[TBL] [Abstract] [Full Text] [Related]
9. Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphoma.
Mohty R; Moreno Vanegas Y; Chavez JC; Kharfan-Dabaja MA
Expert Rev Anticancer Ther; 2023 Feb; 23(2):121-126. PubMed ID: 36662602
[TBL] [Abstract] [Full Text] [Related]
10. High expression of AP2M1 correlates with worse prognosis by regulating immune microenvironment and drug resistance to R-CHOP in diffuse large B cell lymphoma.
Liu X; Zhao X; Yang J; Wang H; Piao Y; Wang L
Eur J Haematol; 2023 Feb; 110(2):198-208. PubMed ID: 36335584
[TBL] [Abstract] [Full Text] [Related]
11. Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12.
Nagao T; Yoshifuji K; Sadato D; Motomura Y; Saito M; Yamamoto K; Yamamoto K; Nogami A
Exp Hematol; 2022 Dec; 116():37-49. PubMed ID: 36191884
[TBL] [Abstract] [Full Text] [Related]
12. Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation.
Zhang B; Zeng J; Zhang H; Zhu S; Wang H; He J; Yang L; Zhou N; Zu L; Xu X; Song Z; Xu S
Front Immunol; 2022; 13():974581. PubMed ID: 36159860
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of albumin as a prognostic factor in HHV-8/HIV-negative Castleman disease from a multicenter study.
Yu T; Cai QQ; Zhai QL; Li L; Fang X; Li J; Sun R; Yang H; Wang Z; Qian W; Xu-Monette ZY; Young KH; Yu L
Leuk Lymphoma; 2022 Dec; 63(13):3082-3091. PubMed ID: 36074798
[TBL] [Abstract] [Full Text] [Related]
14. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract] [Full Text] [Related]
15. Spontaneous regression of dasatinib-related primary effusion lymphoma-like lymphoma.
Hayashino K; Meguri Y; Yukawa R; Komura A; Nakamura M; Yoshida C; Yamamoto K; Oda W; Imajo K
Int J Hematol; 2023 Jan; 117(1):137-142. PubMed ID: 36066839
[TBL] [Abstract] [Full Text] [Related]
16. Construction of three-gene-based prognostic signature and analysis of immune cells infiltration in children and young adults with B-acute lymphoblastic leukemia.
Xiang C; Wu J; Yu L
Mol Genet Genomic Med; 2022 Jul; 10(7):e1964. PubMed ID: 35603962
[TBL] [Abstract] [Full Text] [Related]
17. A case of primary cutaneous anaplastic large cell lymphoma on eyelid.
Gong Y; Chen J; Shi Y
Indian J Dermatol Venereol Leprol; 2022; 88(3):444. PubMed ID: 35389030
[TBL] [Abstract] [Full Text] [Related]
18. The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes.
Shokrgozar N; Dehghani M; Golmoghaddam H; Moghadam M; Rezaei N; Moayed V; Arandi N
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e388-e397. PubMed ID: 35098660
[TBL] [Abstract] [Full Text] [Related]
19. Ferroptosis Markers Predict the Survival, Immune Infiltration, and Ibrutinib Resistance of Diffuse Large B cell lymphoma.
Weng J; Chen L; Liu H; Yang XP; Huang L
Inflammation; 2022 Jun; 45(3):1146-1161. PubMed ID: 35064379
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic implication of ctla-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia-lymphoma.
Onishi A; Fuji S; Kitano S; Maeshima AM; Tajima K; Yamaguchi J; Kawashima I; Kawajiri A; Takemura T; Ito A; Tanaka T; Okinaka K; Inamoto Y; Kurosawa S; Kim SW; Munakata W; Maruyama D; Tobinai K; Fukuda T
Ann Hematol; 2022 Apr; 101(4):799-810. PubMed ID: 35032188
[TBL] [Abstract] [Full Text] [Related]
[Next]
